KLGCX
Price
$45.23
Change
+$0.15 (+0.33%)
Updated
Jul 28 closing price
Net Assets
1.03B
VIGAX
Price
$234.68
Change
+$0.94 (+0.40%)
Updated
Jul 28 closing price
Net Assets
311.95B
Interact to see
Advertisement

KLGCX vs VIGAX

Header iconKLGCX vs VIGAX Comparison
Open Charts KLGCX vs VIGAXBanner chart's image
NYLI WMC Growth
Price$45.23
Change+$0.15 (+0.33%)
VolumeN/A
Net Assets1.03B
Vanguard Growth Index Admiral
Price$234.68
Change+$0.94 (+0.40%)
VolumeN/A
Net Assets311.95B
KLGCX vs VIGAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
KLGCX vs. VIGAX commentary
Jul 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KLGCX is a Buy and VIGAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIGAX has more cash in the bank: 312B vs. KLGCX (1.03B). VIGAX pays higher dividends than KLGCX: VIGAX (0.45) vs KLGCX (0.00). KLGCX was incepted earlier than VIGAX: KLGCX (13 years) vs VIGAX (25 years). KLGCX (2.16) is less costly to investors than VIGAX (0.05). KLGCX is a more actively managed with annual turnover of: 69.00 vs. VIGAX (11.00). KLGCX has a lower initial minimum investment than VIGAX: KLGCX (2500) vs VIGAX (3000). VIGAX annual gain was more profitable for investors over the last year : 26.05 vs. KLGCX (15.59). VIGAX return over 5 years is better than : 113.30 vs. KLGCX (17.91).
KLGCXVIGAXKLGCX / VIGAX
Total Expense Ratio2.080.054,160%
Annual Report Gross Expense Ratio2.160.054,320%
Fund Existence13 years25 years-
Gain YTD10.50611.10795%
Front LoadN/AN/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets1.03B312B0%
Annual Yield % from dividends0.000.45-
Returns for 1 year15.5926.0560%
Returns for 3 years57.9880.9772%
Returns for 5 years17.91113.3016%
Returns for 10 years39.04314.4412%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PMVP1.510.10
+7.09%
PMV Pharmaceuticals
CSTM13.930.26
+1.90%
Constellium SE
CMPX3.200.02
+0.63%
Compass Therapeutics
ASND164.16-3.31
-1.98%
Ascendis Pharma A/S
ALZN2.77-0.19
-6.42%
Alzamend Neuro Inc.